Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Well Lead Med Co Ltd
603309Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. It manufactures and sells urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial tubes, tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products; respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and Convicath intermittent catheter; and ambulatory infusion pump for pain management. The company was founded in 1998 and is headquartered in Guangzhou, China. Address: 47 Guomao Avenue South, Guangzhou, China, 511434
Analytics
Zielpreis von Wall Street
307.2 CNYKGV
18.1892Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 603309
Dividenden-Analyse 603309
Dividendenwachstum über 5 Jahre
195 %Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
35 %Verlauf der Dividende 603309
Bewertung der Aktie 603309
Finanzen 603309
Ergebnisse | 2019 | Dynamik |